Clinical trials
Phase 4 Obesity, Morbid trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 8 |
| Not yet recruiting | 7 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| General Committee of Teaching Hospitals and Institutes, Egypt | 5 |
| Hvidovre University Hospital | 4 |
| Radboud University Medical Center | 4 |
| St. Antonius Hospital | 3 |
| Duke University | 2 |
| University Health Network, Toronto | 2 |
| University of Missouri-Columbia | 2 |
| Zuyderland Medisch Centrum | 2 |
| Baylor College of Medicine | 1 |
| Central Hospital, Nancy, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity, Morbid | 57 |
| Obesity | 12 |
| Weight Loss | 5 |
| Weight Gain | 4 |
| Agnosia | 2 |
| Sleep Apnea, Obstructive | 2 |
| Diabetes Mellitus | 1 |
| Hemorrhage | 1 |
| Hypertension | 1 |
| Hypogonadism | 1 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.